Mounjaro Weight Loss Clinic in India

Last updated on November 14th, 2025 at 10:12 am

In recent months, India has seen a new trend in weight loss treatment with the introduction of Mounjaro, a powerful injectable that combines two hormone actions GLP-1 and GIP to help people lose weight effectively while managing blood sugar.

What Is Mounjaro and How Does It Work?

Mounjaro (tirzepatide) is made by Eli Lilly and is gaining popularity because it not only controls diabetes but also helps reduce weight by making you feel full quickly and curbing cravings. Clinical trials suggest weight loss of 15% to 20% body weight, a result comparable to some surgeries, as reported in several studies, including global trials.

Mounjaro Journey in India:

Eli Lilly launched the Mounjaro KwikPen in India in August 2025, offering a convenient weekly pre-filled injection. Before this, obtaining such medication meant sourcing from abroad or unreliable local channels. Now, with authorised, locally priced versions available, many Indian patients find it more accessible and legal.

India has responded enthusiastically. Sales have grown quickly by May 2025, over 81,000 units were sold, amounting to ₹239 million, with a 60% rise in sales between April and May alone. Alongside, weight loss clinics and hospitals report receiving hundreds of patient enquiries within days of the launch.

Available Formats in India:

1. Vials (since March 2025)
Eli Lilly first made Mounjaro available in India in late March 2025 in 2.5 mg and 5 mg vial forms. These were intended for weekly injections and quickly gained popularity.

2. KwikPen (launched August 2025)
In August 2025, the Indian drug regulator approved the Mounjaro KwikPen, a user-friendly prefilled pen with six dose strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg.

Which Should You Choose?

Vials are more affordable for simple, low dose needs (2.5 mg or 5 mg weekly). Ideal if your doctor only recommends these strengths.

KwikPens bring greater convenience, precision, and ease of use, perfect for busy individuals or those needing higher doses (7.5 mg to 15 mg). Still, they cost the same per month for matching low doses.

Before and After Results of Weight Loss Injections:

Dr Nivedita Dadu, a practising dermatologist in India, shared that she lost 14 kg in about four months using Mounjaro along with lifestyle changes. Meanwhile, filmmaker Hansal Mehta publicly revealed his 10 kg weight loss, also with Mounjaro, and pre-diabetes control but his doctor warned that most weight can return within a year if healthy habits aren’t maintained.

What Clinics Are Offering Mounjaro in India?

Specialised clinics in major cities like Delhi, Mumbai and Hyderabad now offer Mounjaro under medical supervision. For instance:

• In Delhi, Hindivine Healthcare by Dr Rajat Goel provides tailored treatment plans combining Mounjaro injections with nutrition, lifestyle coaching and monitoring.

• In Mumbai, many clinics offer expert metabolic care with carefully adjusted dosing and holistic support.

Important Considerations While Taking Mounjaro:

While Mounjaro shows promise, doctors emphasise that it is not a magic fix. It should be part of a larger plan including diet, exercise, and lifestyle changes. Without these, any weight lost may return.

India’s Weight Loss Drug Market

India’s weight loss drug market is rapidly expanding. With rising obesity rates and increasing drug availability, demand for medications like Mounjaro is booming. Analysts expect global weight loss drug market to grow to US$150-175 billion in coming years. In India, domestic companies like Sun Pharma and Cipla are preparing generic versions expected after patent expiry around 2026.

In summary, Mounjaro clinics in India are offering a promising medical path to weight loss, not only through the drug itself but also with proper medical oversight and lifestyle support. However, sustained results depend on combining treatment with healthy habits.

FAQs related to Mounjaro in India:

Q1. What formats of Mounjaro are available in India?

Mounjaro is available in vials (2.5 mg, 5 mg) and KwikPens (2.5 mg to 15 mg).

Q2. Which is better: Vial or KwikPen?

Vials are cheaper for low doses, while KwikPens are easier to use and cover higher doses

Q3. What is Mounjaro and how does it work for weight loss?

Mounjaro (tirzepatide) is an injection made by Eli Lilly. It works on two hormones GLP-1 and GIP that control appetite and blood sugar. It makes you feel full faster, reduces hunger, and helps in losing weight.

Q4. Is Mounjaro available in India?
Yes, Mounjaro was officially launched in India in August 2025. The KwikPen is now sold in Indian pharmacies.

Q5. Do I need a doctor’s prescription for Mounjaro?
Yes, Mounjaro is a prescription medicine. You cannot buy it directly without a doctor’s consultation. Most clinics in Delhi, Mumbai, and other cities provide treatment under medical supervision to ensure safety.

Q6. How much weight can I lose with Mounjaro?
Clinical studies show that people can lose up to 15-20% of their body weight in one year.

Q7. Are there any side effects of Mounjaro?
Yes, common side effects include nausea, vomiting, diarrhoea, constipation, and stomach pain.

Q8. Where can I get Mounjaro weight loss treatment in India?
Many clinics in Delhi, Mumbai and Hyderabad offer Mounjaro under medical care. Including Dr Rajat Goel’s clinic in Lajpat Nagar, New Delhi offers the same.

Q9. Is Mounjaro better than Wegovy or Ozempic?
Mounjaro is considered more effective in weight loss than Wegovy (semaglutide) in some studies, because it acts on two hormones instead of one.

Q10. Will the weight come back if I stop Mounjaro?
Yes, most of the lost weight can return if you stop using it without lifestyle changes. Doctors advise continuing with healthy eating, exercise, and regular check-ups to maintain results.

Q11. Are cheaper or generic versions available in India?
Right now, only Eli Lilly’s Mounjaro is available. Indian companies like Sun Pharma and Cipla are expected to launch generic versions after 2026 when patents expire, as reported in Reuters.

Q12. Who should avoid Mounjaro?
Pregnant or breastfeeding women, people with certain thyroid cancers, pancreatitis or severe kidney/liver issues should not take Mounjaro. Always consult a doctor before starting treatment.